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Introduction
Peroxisomes are small membrane-bound organelles that func-
tion in cellular metabolism in diverse ways, including the 
β- and α-oxidation of fatty acids, the oxidation of bile acids and 
cholesterol, and conversion of hydrogen peroxide to nontoxic 
forms. The peroxisome’s importance in lipid metabolism and 
defense against oxidative stress explains why defects in peroxi-
some biogenesis underlie several severe inherited diseases 
known as peroxisomal biogenesis disorders, including Zellwe-
ger syndrome, infantile Refsum disease, and neonatal adreno-
leukodystrophy (Wanders, 2004).
Genetic and proteomic studies in yeast and mammalian 
cell systems have led to the identifi  cation of up to 32 proteins 
(collectively called peroxins or PEX) involved in peroxisome 
biogenesis. Of these peroxins, three in mammalian cells—
PEX3, PEX16, and PEX19—and two in yeast cells—Pex3p 
and Pex19p—are specifi  cally involved in peroxisomal mem-
brane protein (PMP) import (Schliebs and Kunau, 2004; for 
  review see Heiland and Erdmann, 2005). When any of these 
proteins are absent or mutated in cells, peroxisomes disappear. 
PEX19, a farnesylated protein found in both cytosol and per-
oxisomes, binds nascent PMPs in the cytoplasm and targets 
them to the peroxisomal membrane (Jones et al., 2004). PEX3, 
an integral membrane protein, acts as a docking receptor for 
incoming complexes of PEX19 and its PMP cargoes (Fang 
et al., 2004). PEX16, an integral membrane protein absent in 
most yeast, is thought to serve as a receptor for PEX3 or as a 
component of the membrane translocator (Honsho et al., 2002; 
Fang et al., 2004).
Despite knowledge of the essential components involved 
in peroxisome biogenesis, the origin of peroxisomes has been 
controversial. The long-standing view is that peroxisomes are 
semiautonomous organelles, like mitochondria and chloro-
plasts, which multiply strictly by growth and division (Lazarow 
and Fujiki 1985; for review see Heiland and Erdmann, 2005). 
This view is based on the premise that peroxisomal proteins 
(both matrix and membrane associated) are synthesized on free 
ribosomes and are imported directly into peroxisomes from the 
cytoplasm (Lazarow, 2003). However, unlike mitochondria and 
chloroplasts, peroxisomes can disappear from a cell and be 
  regenerated de novo. For example, cells defective in PEX3, 
PEX16, or PEX19 do not have any detectable peroxisomes; yet, 
upon introduction of the wild-type version of the missing or 
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mutated gene, peroxisomes are quickly regenerated (South and 
Gould, 1999; Honsho et al., 2002). This capacity of peroxi-
somes to regenerate, together with other observations related to 
the intracellular sorting pathways of PMPs (see the following 
paragraph), has led to an alternative view of peroxisomal bio-
genesis, in which other organelles—specifi  cally, the ER—
  participate in the formation and maintenance of peroxisomal 
membranes (for reviews see Heiland and Erdmann, 2005; 
  Kunau, 2005; Schekman, 2005).
Several lines of experimental support for an ER-dependent 
mode of peroxisome biogenesis, especially in yeast and plants, 
have been obtained over the past few years. For example, in 
the yeast cell type Yarrowia lipolytica, Pex16p and Pex2p are 
N-glycosylated (a modifi  cation only occurring in the ER), sug-
gesting they pass through the ER en route to peroxisomes 
  (Titorenko and Rachubinski, 1998). In plant cells, both Arabi-
dopsis thaliana Pex16p and cottonseed peroxisomal ascorbate 
peroxidase localize to a distinct subdomain of the ER called 
peroxisomal ER in addition to being found in peroxisomes 
(Mullen et al., 1999; Karnik and Trelease, 2005). Finally, in 
Saccharomyces cerevisiae cells, peroxisomes reappear by out-
growth of Pex3-GFP–containing structures from the ER during 
complementation of ∆Pex3p mutants with Pex3p-GFP (Hoepfner 
et al., 2005; Tam et al., 2005). In addition, Pex3p that is targeted 
to the ER by an attached signal sequence is routed to peroxi-
somes (Kragt et al., 2005). In yeast and plant cells, therefore, 
the ER seems to play a direct role in delivering lipid and protein 
components to peroxisomes.
Whether the ER plays a similar role in peroxisome bio-
genesis in mammalian cells remains unclear. The only evidence 
suggesting this comes from studies in mouse dendritic cells, in 
which PEX13 and PMP70 have been reported in reticular struc-
tures apparently connected to smooth ER (Geuze et al., 2003). 
Other studies have provided results that are inconsistent with an 
ER role. Exogenously expressed PEX3 or PEX19, for example, 
are not localized to the ER in mammalian cells, even when they 
are overexpressed in peroxisome-defi  cient cells (Fang et al., 
2004). Because PEX3 does not directly target to the ER in mam-
malian cells or in plant cells (Hunt and Trelease, 2004), the fi  nd-
ings in S. cerevisiae related to Pex3p traffi  cking (and potentially 
its conclusions regarding the role of the ER in peroxisome bio-
genesis) may not be generalizable to all organisms. Indeed, per-
oxisome biogenesis in mammalian cells is widely assumed to 
occur primarily by fi  ssion of preexisting peroxisomes with any 
de novo pathway, either ER dependent or independent (for 
  reviews see Lazarow, 2003; Yan et al., 2005), occurring only 
under unusual conditions in mutated cells. The role of the ER 
in the biogenesis of mammalian peroxisomes would therefore 
seem to be limited to providing membrane components (e.g., 
lipids) rather than to providing a platform for the outgrowth of 
new peroxisomes, as observed in S. cerevisiae cells (Hoepfner 
et al., 2005; Kragt et al., 2005; Tam et al., 2005).
These types of concerns have led us to directly investigate 
the pathway for peroxisome biogenesis in mammalian cells. 
  Toward this end, we have used monomeric and photoactivated 
versions of GFP linked to the essential membrane peroxin, 
PEX16, to address whether specifi  c  peroxisomal  membrane 
components in mammalian cells are normally derived from the 
ER or whether this occurs only when preexisting peroxisomes 
are missing. We furthermore have used a novel photo-chase strategy 
highlighting old and new peroxisomes to address whether new 
peroxisomes in mammalian cells form primarily by growth and 
division of preexisting peroxisomes or by the maturation of new 
peroxisomes derived from the ER. Our fi  ndings provide the fi  rst 
direct evidence in mammalian cells that the ER plays a central 
role in both the origin and maintenance of peroxisomes.
Results
PEX16 localizes to peroxisomes 
and ER and is not present in cytosol
To characterize the dynamic distribution of human PEX16, the 
COOH terminus of PEX16 was tagged with monomeric ver-
sions of various fl   uorescent proteins (GFP, photoactivatable 
GFP [PAGFP], or Venus). Two lines of evidence suggested that 
all of the resulting chimeras targeted and functioned properly 
when expressed in mammalian cells. First, when PEX16 tagged 
with GFP (PEX16-GFP) was expressed in COS-7 cells, com-
plete colocalization was observed between PEX16-GFP and a 
coexpressed peroxisomal reporter molecule consisting of the 
red fl  uorescent protein (RFP) tagged to type 1 peroxisomal 
  matrix targeting signal, SKL-COOH (RFP-SKL; Fig. 1 A). 
  Second, in cells from the human fi  broblast cell line GM06231 
lacking peroxisomes because of a mutated PEX16 gene, intro-
duction of PEX16-GFP led to the appearance of new peroxi-
somes (Brocard et al., 2005), indicating PEX16-GFP can 
complement PEX16 function.
COS-7 cells expressing PEX16-GFP at higher levels, 
achieved by increasing the time between cell transfection and 
imaging (from 15 to 24 h; Fig. S1, available at http://www.jcb.
org/cgi/content/full/jcb.200601036/DC1), were examined to 
determine whether PEX16-GFP changed its distribution once 
the machinery involved in PEX16 sorting to peroxisomes be-
came limited by PEX16 overexpression. To identify peroxi-
somes as well as ER in these cells, the peroxisomal marker 
RFP-SKL and the ER marker ssRFP-KDEL were individually 
coexpressed with PEX16-GFP. The distribution of PEX16-GFP 
in these cells included the ER as well as peroxisomes (Fig. 1 C). 
Hence, the membrane localization of PEX16-GFP is not re-
stricted to peroxisomes but includes the ER under conditions of 
high PEX16-GFP expression.
Expression of PEX16-GFP at low levels in the peroxi-
some biogenesis disorder (PBD) 399-T1 human fi  broblast cell 
line that lacks PEX19 and in which peroxisomes are absent 
(Sacksteder et al., 2000) showed the chimera residing exclu-
sively in the ER, with RFP-SKL diffusely distributed through-
out the cytosol (Fig. 1 E). A similar ER pattern was observed for 
PEX16-GFP expressed in a PEX3 mutant human fi  broblast cell 
line (PBD400) that, similar to PBD399-T1 cells, lacks peroxi-
somes (South et al., 2000; unpublished data). When peroxi-
somes are absent, therefore, PEX16-GFP targets to the ER and 
not to the cytosol. Cell fractionation and immunoblot analysis 
of PEX16-GFP–transformed COS-7 cells performed 24 h after 
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PEX16-GFP resided only in the membrane (or nonsoluble 
 fraction), in contrast to GFP expressed alone, which was primarily 
in the soluble fraction (Fig. 1 G). Hence, PEX16-GFP does not 
appear to ever reside in the cytosol.
Peroxisomes that were observed in cells having high 
PEX16-GFP expression were closely aligned with the ER (Fig. 
1 C [box] and D), suggesting that peroxisomes and the ER are 
intimately associated. Repetitive photobleaching (or fl  uores-
cence loss in photobleaching [FLIP]) of PEX16-GFP fl  uores-
cence in a small, centralized area of the ER in these cells (Fig. 
1 F, red box) resulted in PEX16-GFP fl  uorescence being lost 
throughout the ER without affecting PEX16-GFP fl  uorescence 
in surrounding peroxisomes (Fig. 1 F). Molecules of PEX16-
GFP can thus freely diffuse throughout the ER, whereas they 
are retained within individual peroxisomes.
Photoactivated PEX16-PAGFP moves 
from the ER to peroxisomes
To investigate whether the ER localization of PEX16 repre-
sented an intermediate in the pathway for delivery of PEX16 to 
peroxisomes, we developed a photo/pulse-chase–labeling assay 
using PEX16 attached to PAGFP (PEX16-PAGFP). PAGFP is 
undetected until “activated” by high-energy light, whereupon 
it becomes brightly fl  uorescent. Activated PAGFP molecules 
remain fl  uorescent over time, whereas PAGFP molecules that 
have not been photoactivated (including newly synthesized and 
newly folded forms) stay invisible (Patterson and Lippincott-
Schwartz, 2002).
The photo/pulse-chase assay was performed in COS-7 
cells coexpressing PEX16-PAGFP and RFP-SKL 24 h after 
transfection, as outlined in Fig. 2 A. Initially, a small region of 
interest (ROI; Fig. 2 A, red box) containing only ER (blue) and 
no peroxisomes (red) was repeatedly irradiated over 30 min 
with 413-nm light (pre-PA). Because PEX16-GFP diffuses 
freely throughout the ER, most PEX16-PAGFP molecules in 
the ER should become photoactivated (Fig. 2 A, green) under 
this treatment. An image of the cell was collected sequentially 
in the 543-nm channel to visualize peroxisomes containing 
RFP-SKL immediately before and after each photoactivation to 
ensure no peroxisomes moved into the ROI and that no PEX16-
PAGFP molecules within peroxisomes become photoactivated. 
After photoactivation in this manner for 30 min, images of 
PEX16-PAGFP at 488-nm fl  uorescence and RFP-SKL at 543-nm 
fl  uorescence were acquired (Fig. 2 A, Post-PA t = 0 min). 
The cell was then incubated for 5 h (chase) before acquiring an-
other set of images (Fig. 2 A, Post-PA t = 5 h) to assess whether 
fl  uorescent PEX16-PAGFP molecules had redistributed to RFP-
SKL–containing peroxisomes.
As shown in Fig. 2 B, before photoactivation of the ER 
pool of PEX16-PAGFP, GFP fl  uorescence (excited at 488 nm) 
was negligible, whereas the fl  uorescence attributable to RFP-
SKL (543 nm) was readily visible and localized primarily to 
individual (punctate) peroxisomes (Fig. 2 B, Pre-PA). Upon 
repeated photoactivation of the small ROI in the lower left part 
of the cell, PEX16-PAGFP fl  uorescence became visible in the 
ER and in a few puncta that partially overlapped with RFP-
SKL, suggesting they were peroxisomes (Fig. 2 B, Post-PA 
Figure 1.  PEX16-GFP localizes to both peroxisomes and ER. (A) COS-7 
cells transiently coexpressing PEX16-GFP and RFP-SKL imaged 15 h after 
transfection. (B) COS-7 cells coexpressing PEX16-GFP and ssRFP-KDEL 
  imaged 24 h after transfection. (C) Same as A except the cells were imaged 
24 h after transfection. (D) Enlargement of the region outlined by the stripped 
box in C. Note that PEX16-GFP and RFP-SKL–containing peroxisomes are in 
close proximity to the ER. (E) PBD399-T1 cell transiently coexpressing PEX16-
GFP and RFP-SKL imaged 24 h after transfection. (F) FLIP of the cell shown in 
C reveals that PEX16-GFP is highly mobile in the ER. The red box outlines the 
ROI that was subjected to photobleaching with 488-nm laser light. The dot-
ted box (enlarged in inset) shows that PEX16-GFP ﬂ  uorescence in peroxi-
somes was unaffected by FLIP, in contrast to PEX16-GFP ﬂ  uorescence in the 
ER. (G) Immunoblots of cell fractions from COS-7 cells transiently expressing 
either GFP or PEX16-GFP. The soluble (S), membrane (P), and prefraction-
ated (T) samples were analyzed by SDS-PAGE/immunoblotting using mouse 
anti-GFP and goat anti–mouse HRP. Bars: (A–C and E) 10 μm; (D) 5 μm.JCB • VOLUME 173 • NUMBER 4 • 2006  524
t = 0 min, arrows). After the 5-h chase period, signifi  cantly 
more PEX16-PAGFP fl   uorescence was localized in peroxi-
somes (Fig. 2 B, Post-PA t = 5 h, arrows). Quantifi  cation of 
peroxisomes containing both PEX16-PAGFP and RFP-SKL 
over the 5-h chase period in fi  ve independent experiments re-
vealed that 10–40% of all peroxisomes in these cells became 
labeled with photoactivated PEX16-PAGFP (unpublished 
data). Because PEX16-PAGFP molecules were pulse-labeled 
in the ER and later appeared in peroxisomes, the data suggested 
that PEX16-PAGFP undergoes specifi  c transport from the ER 
to peroxisomes.
PEX16 movement from ER to peroxisomes 
depends on sequences in its NH2 terminus
To investigate what molecular features of PEX16 were necessary 
for it to pass from the ER to peroxisomes, we used a PAGFP-
tagged variant of PEX16 in which the NH2-terminal membrane 
peroxisome–targeting  sequence  (residues  66–81;  -R K E L R K K-
L P V S L S Q Q K -;  Honsho  et  al.,  2002)  was  deleted.  Expression 
of this construct (delPEX16-PAGFP) in COS-7 cells resulted 
in only an ER pattern of localization with no peroxisome la-
beling (Fig. S2, available at http://www.jcb.org/cgi/content/
full/jcb.200601036/DC1). In the photo-chase assay, photoacti-
vation of the ER pool of a cell expressing delPEX16-PAGFP 
resulted in the fl  uorescence attributable to delPEX16-PAGFP 
never redistributing to peroxisomes and remaining within the 
ER (Fig. 2 C). The small structures containing photoactivated 
delPEX16-PAGFP seen in the juxtanuclear region of these cells 
(Fig. 2 C, Post-PA t = 0 min and Post-PA t = 5 h) presumably 
represented compacted ER cisternae, as their fl  uorescence was 
diminished upon repeated photobleaching of a small area of ER 
in delPEX16-GFP–expressing cells (Fig. S2). Thus, delivery of 
PEX16 from ER to peroxisomes is dependent on the membrane 
peroxisome–targeting sequence found within PEX16.
PEX16 with an appended NH2-terminal 
type I signal anchor sequence targets 
to peroxisomes after being synthesized 
in the ER
Nascent polypeptides containing an NH2-terminal signal se-
quence are bound by the signal recognition particle in the cyto-
plasm and transferred to the ER before the remainder of their 
mRNA is translated (Rapoport et al., 1996). By attaching such a 
sequence to the NH2 terminus of PEX16, we reasoned that we 
could force newly synthesized PEX16 proteins to be cotransla-
tionally inserted into the ER before they targeted elsewhere in 
the cell (such as to peroxisomes). With such a construct, we 
could then address whether PEX16 could target to peroxisomes 
after being cotranslationally synthesized in the ER. We appended 
residues 14–90 from the well-defi  ned type I signal anchor se-
quence of leader peptidase (designated as sa; Gafvelin et al., 
1997; Heinrich et al., 2000) to the NH2 terminus of PEX16-GFP 
(yielding saPEX16-GFP) to preserve the native (Nout-Cout; Fig. 
3 A) membrane topology of PEX16 (Honsho et al., 2002). 
Figure 2.  Photo/pulse-chase assay indicates that PEX16-PAGFP, but not delPEX16-GFP, sorts from the ER to peroxisomes. (A) Schematic diagram of the 
photo/pulse-chase assay. (B) Photo/pulse-chase assay performed in COS-7 cell coexpressing PEX16-PAGFP and RFP-SKL. To ensure that all newly synthe-
sized PEX16-PAGFP molecules had time to correctly fold and target to membranes, the cells were treated with 100 μM puromycin before photoactivation. 
The red box indicates the ROI. Arrows indicates examples of obvious colocalizations of PEX16-PAGFP and RFP-SKL. The insets display the corresponding 
merged images of coexpressed PEX16-PAGFP (green) and RFP-SKL (red). (C) Photo/pulse-chase assay was performed as described in B, except cells were 
coexpressing delPEX16-PAGFP and RFP-SKL. Insets represent enlarged merged images of the dotted boxes showing the localization of delPEX16-PAGFP 
(green) and RFP-SKL (red). Bars, 10 μm. DE NOVO BIOGENESIS OF PEROXISOMES FROM THE ER • KIM ET AL. 525
  Evidence that sa functioned properly as a signal sequence for tar-
geting of proteins to the ER was demonstrated by appending it 
to GFP alone (producing saGFP) and expressing the construct in 
COS-7 cells treated with brefeldin A to block secretory transport 
out of the ER. In these cells, saGFP accumulated in the ER (Fig. 
3 B), whereas untagged GFP expressed in COS-7 cells was dis-
tributed diffusely throughout the cytosol and nucleus (Fig. 3 C).
To test whether saPEX16-GFP could target to peroxisomes 
after biosynthesis in the ER, we examined COS-7 cells coexpres  s-
ing saPEX16-GFP and ssRFP-KDEL 15 h after transfection. 
A large pool of saPEX16-GFP could be seen colocalized with 
ssRFP-KDEL in the ER (Fig. 3 D). Differential permeabili-
zation and antibody binding experiments demonstrated that 
  saPEX16-GFP in the ER maintained the same Cout topology as 
that of PEX16-GFP (Fig. S3, available at http://www.jcb.org/
cgi/content/full/jcb.200601036/DC1). Repetitive photobleaching 
(i.e., FLIP) of saPEX16-GFP fl  uorescence in an area of ER 
abolished saPEX16-GFP fl  uorescence throughout the ER and 
revealed a pool of saPEX16-GFP fl  uorescence in peroxisomes 
(Fig. 3, E and F; note the localization of saPEX16-GFP– in 
RFP-SKL–containing peroxisomes in Fig. 3 F). Therefore, 
  saPEX16-GFP can undergo transport to peroxisomes after being 
synthesized in the ER.
When the cells were imaged at earlier times after transfec-
tion (8 h) to examine saPEX16-GFP localization at lower ex-
pression levels, saPEX16-GFP was exclusively colocalized with 
RFP-SKL in peroxisomes (Fig. 3 G). A possible explanation for 
this is that saPEX16-GFP moves effi  ciently from ER to peroxi-
somes until excess saPEX16-GFP saturates the machinery for 
targeting to peroxisomes. Consistent with this, time-lapse imag-
ing of cells expressing saPEX16-GFP over a 10-h period (during 
which saPEX16-GFP expression levels went from low to high) 
revealed newly synthesized saPEX16-GFP accumulating in 
  peroxisomes before also accumulating in the ER (Fig. 3 H).
Figure 3.  PEX16 containing an NH2-terminal signal-anchor sequence 
  localizes to both peroxisomes and ER. (A) Illustration of the predicted topo-
logies of PEX16-GFP, saPEX16-GFP, and saGFP. sa sequences are shown in 
red, PEX16 in black, and GFP in green. The asterisk indicates the approxi-
mate location of the glycosylation site engineered in PEX16-glyc. (B and C) 
Images of COS-7 cells transiently transfected with either saGFP (B) or GFP 
(C) after treatment with 5 μg/ml brefeldin A to block export of proteins 
from the ER. (D) COS-7 cell coexpressing saPEX16-GFP and ssRFP-KDEL 
imaged 15 h after transfection. (E and F) Cells coexpressing saPEX16-GFP 
and RFP-SKL before (E) and after (F) FLIP with 488-nm laser light. (G) Same 
as E except cells were imaged 8 h after transfection. (H) Time-lapse images 
of cells expressing saPEX16-GFP at 8, 10, 16, and 18 h after transfection. 
Bars, 10 μm.
Figure 4.  saPEX16- and PEX16-GFP rescue PEX16-deﬁ  cient GM06231 cells. 
(A–C) GM06231 cells were transiently transfected with pRFP-SKL alone (A) 
or cotransfected with RFP-SKL and either PEX16-GFP (B) or   saPEX16-GFP 
(C). Live cells were imaged 48 h after transfection. The solid arrows in 
B and C indicate colocalization between the GFP and RFP signals. The 
open arrows indicate punctate structures containing either PEX16- or 
  saPEX16-GFP only. The insets show enlarged portions of the cells outlined 
by dotted boxes. (left) Images excited at 488 nm; (right) images excited at 
543 nm. Bars, 10 μm. JCB • VOLUME 173 • NUMBER 4 • 2006  526
PEX16 with a signal anchor sequence 
complements wild-type PEX16 in cells 
lacking the PEX16 gene
To determine whether saPEX16-GFP could complement PEX16 
function and give rise to new peroxisomes, cells from the hu-
man GM06231 cell line lacking peroxisomes were transfected 
with RFP-SKL, PEX16-GFP and RFP-SKL, or saPEX16-GFP 
and RFP-SKL. The distribution of GFP and/or RFP fl  uores-
cence in these cells was then examined 48 h after transfection 
(Fig. 4). In cells transfected with RFP-SKL alone, the peroxi-
somal reporter was distributed diffusely in the cytosol and no 
fl  uorescence at 488 nm was detected, indicating that peroxi-
somes were indeed absent in these cells (Fig. 4 A). In contrast, 
in cells cotransfected either with PEX16-GFP and RFP-SKL 
(Fig. 4 B) or with saPEX16-GFP and RFP-SKL (Fig. 4 C), nu-
merous punctate and globular peroxisomal structures contain-
ing both sets of expressed proteins were observed (Fig. 4, B and C, 
arrows). Because the signal anchor sequence on saPEX16-GFP 
forced it to be inserted into the ER membrane before delivery to 
other membranes, these results indicated that a pathway from 
the ER involving PEX16 was suffi  cient to support peroxisome 
production de novo.
Interestingly, some of the punctate structures in the cells 
  coexpressing the GFP-tagged PEX16 and RFP-SKL molecules 
contained only PEX16- or saPEX16-GFP. These structures may 
represent so-called early or nascent peroxisomes (South and Gould, 
1999; Honsho et al., 2002) that have not yet begun importing 
  lumenal peroxisomal proteins after PEX16 complementation.
Wild-type PEX16 inserts into ER 
membranes in a cotranslational, rather 
than posttranslational, manner in vitro
There are two ways in which wild-type nascent PEX16 can 
  target to the ER: (1) by posttranslational targeting, in which 
PEX16 is synthesized on free ribosomes in the cytoplasm and 
then is posttranslationally targeted to and inserted into ER 
membranes, or (2) by cotranslational targeting, in which ribo-
somes containing NH2-terminal PEX16-nascent chains are fi  rst 
targeted to the ER and then PEX16 is cotranslationally inserted 
into ER membranes. To distinguish between these two possibil-
ities, we used an in vitro binding assay in which PEX16 was 
synthesized using a rabbit reticulocyte lysate in the presences 
of 
35S-methionine. To assay for cotranslational targeting, the 
translation reaction was performed in the presence of ER 
 microsomes. To assay for posttranslational targeting, ER micro-
somes were added to the reaction after the protein was fi  rst fully 
translated and further protein translation was inhibited by the 
addition of cycloheximide. Preprolactin (PPL) and cytochrome 
b5-glyc (Cb5-glyc; cytochrome b5 with a glycosylation site in its 
luminal domain) were used as appropriate cotranslation and 
posttranslation controls, respectively (Andrews et al., 1989; 
  Pedrazzini et al., 2000).
As shown in Fig. 5 (A and B), PEX16 pelleted more 
readily with ER microsomes during cotranslational targeting 
(39%) than during posttranslational targeting (18%) or during 
translation without microsomes (10%). These results were 
similar to those observed for the cotranslational targeting of 
PPL; i.e., signifi  cantly more PPL pelleted with microsomes 
with its signal sequence cleaved during co-T2 targeting com-
pared to post-T2 targeting (Fig. 5 A [PPL, compare lane 3 
with 6 and 9] and B). In contrast, Cb5-glyc exhibited binding 
to ER microsomes both when microsomes were added during 
the translation reaction and when microsomes were added 
  after translation (Fig. 5 A, Cb5-glyc), as expected for this 
  posttranslationally targeted protein (Pedrazzini et al., 2000). 
Furthermore, the actual integration of Cb5-glyc into ER 
  microsomes was demonstrated by its glycosylation, which 
shifted it to a higher molecular mass in the pellet fraction 
(Fig. 5 A, lanes 3 and 6).
The increase of PEX16 in the pellet fraction during post-
translational targeting experiments compared with minus 
membrane experiments (Fig. 5, A and B) may be due to non-
specifi  c interactions of PEX16’s hydrophobic transmembrane 
domains with microsomes rather than to PEX16’s actual inte-
gration into the lipid bilayer of the ER. To determine whether 
Figure 5.  PEX16 targets cotranslationally to ER in vitro. (A) Autoradio-
graphs of the in vitro ER microsome binding assays with PPL ( 30 kD), Cb5-
glyc ( 20 kD), and PEX16 ( 37 kD) in both cotranslational (co-T2) targeting 
and posttranslational (post-T2) conditions. Lanes represents fractions from 
membrane pelleting over a sucrose cushion. The lower molecular mass band 
in lane 3 for PPL is due to the processing of the PPL’s cleavable signal 
  sequence. The higher molecular mass band in lanes 3 and 6 for Cb5-glyc is 
due to its N-linked glycosylation. −mbs, no ER microsomes; S, supernatant; 
C, cushion; P, pellet. (B) Representative histograms illustrating the percentage 
of total protein accumulated in the pellet after either co-T2 or post-T2 target-
ing or when no ER microsomes were included in the binding assays. Error 
bars indicate one standard deviation. n = 3. (C) In vitro ER microsome bind-
ing assays with PEX16-glyc. Procedures similar to those in A were followed; 
however, pelleted membranes were washed with 0.5 M KOAc and 50 mM 
EDTA after centrifugation. The higher molecular mass band in lane 3 repre-
sents glycosylated PEX16-glyc protein in the pelleted ER microsomes.DE NOVO BIOGENESIS OF PEROXISOMES FROM THE ER • KIM ET AL. 527
this was the case, we engineered a glycosylation site at the pu-
tative luminal domain of PEX16 (PEX16-glyc; N-X-S starting 
at residue 161; Fig. 3 A). We reasoned that if any PEX16-glyc 
molecules in the assay were glycosylated, they must have been 
specifi  cally integrated into ER microsomes. As shown in Fig. 5 C, 
a signifi  cant proportion of PEX16-glyc molecules underwent 
glycosylation during cotranslational targeting, whereas none did 
so during posttranslational targeting. The data thus confi  rmed 
that PEX16 undergoes cotranslational insertion into the ER 
  under in vitro conditions.
PEX16 can recruit other PMPs to the ER
It was previously hypothesized that PEX16 acts as part of the 
machinery involved in recruiting PMPs to membranes (Honsho 
et al., 2002; Fang et al., 2004). If so, overexpressed PEX16 that 
is localized to the ER should cause other PMPs, such as PEX3 
and PMP34, to retarget to ER membranes. To test this predic-
tion, we constructed chimeras of PEX3 and PMP34 fused to the 
GFP or Cerulean blue fl  uorescent protein (Rizzo et al., 2004) 
and examined their subcellular location in the presence or ab-
sence of overexpressed PEX16 fused to the Venus fl  uorescent 
protein (PEX16-Venus; Nagai et al., 2002).
Neither PEX3- nor PMP34-GFP was targeted to the ER 
when expressed in cells lacking peroxisomes (Fig. S4, available 
at http://www.jcb.org/cgi/content/full/jcb.200601036/DC1) or 
in cells containing peroxisomes (Fig. 6, A, B, D, and E). Indeed, 
PEX3-GFP was colocalized exclusively with RFP-SKL in per-
oxisomes at low expression levels (Fig. 6 A) and accumulated 
in mitochondria at higher expression levels (Fig. 6 B). PMP34-
Cerulean was also localized to peroxisomes at low expression 
levels (Fig. 6 D) but accumulated in the cytoplasm at higher ex-
pression levels (Fig. 6 E). Importantly, when PEX16-Venus was 
coexpressed with either PEX3- or PMP34-Cerulean, both PMPs 
colocalized with PEX16-Venus in the ER (Fig. 6, C and F). 
When a small area of the ER was repeatedly photobleached to 
remove ER fl  uorescence in cells coexpressing the PMPs and 
PEX16-Venus, both PMPs were observed in peroxisomes 
  (unpublished data). Similar colocalizations of PEX16-Venus 
and PEX3-Cerulean in the ER were observed in the PBD399-T1 
fi  broblast cells lacking peroxisomes (Fig. S4), indicating that 
the   recruitment of PEX3-Cerulean by PEX16-Venus to the ER 
also occurred in other cells. Hence, PEX16 appears to function 
in the recruitment of PEX3 and PMP34, and possibly other 
PMPs, to membranes.
Distinguishing de novo peroxisome 
biogenesis from peroxisome ﬁ  ssion 
in wild-type cells
Recent studies in S. cerevisiae cells have suggested that 
de novo biogenesis of peroxisomes occurs by direct outgrowth 
of peroxisomal structures from the ER (Hoepfner et al., 2005; 
Kragt et al., 2005; Tam et al., 2005). To test whether a similar 
mechanism occurs in mammalian cells, we devised an assay to 
directly visualize the formation of peroxisomes in wild-type 
mammalian cells (Fig. 7 A). The assay involved two photo-
activation events separated by 24 h that permitted old and new 
peroxisomal components to be differentiated in living cells. 
We reasoned that daughter peroxisomes formed by division of 
preexisting peroxisomes should all contain peroxisomal com-
ponents from their mother peroxisomes. However, peroxisomes 
formed by a de novo pathway from the ER should contain only 
newly synthesized components. Therefore, by distinguishing re-
cently synthesized peroxisomal components from older peroxi-
somal components, we could distinguish peroxisomes formed 
de novo from those formed by fi  ssion.
Figure 6.  PEX16 recruits PEX3 and PMP34 to the ER. (A and B) COS-7 
cells either coexpressing PEX3-GFP and pRFP-SKL 15 h after transfection 
(A) or expressing PEX3-GFP and stained with MitoTracker 24 h after trans-
fection (B). (C) A COS-7 cell expressing PEX16-Venus and PEX3-Cerulean 
24 h after transfection. (D and E) COS-7 cells coexpressing PMP34-GFP 
and RFP-SKL were imaged either 15 h (D) or 48 h (E) after transfection. 
(F)  Cell coexpressing PEX16-Venus and PMP34-Cerulean imaged 24 h 
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NRK cells were transiently transfected with PAGFP fused 
to SKL (PAGFP-SKL) to mark preexisting peroxisomes and 
with PEX16-Cerulean to monitor peroxisomes before (pre-PA) 
and after (post-1st PA t = 0 h) photoactivation of PAGFP-SKL 
(Fig. 7 A). All PAGFP-SKL molecules in the peroxisomes of the 
cell were initially photoactivated using 413-nm laser light, and 
an image was collected (post-1st PA t = 0 h). The cell was then 
incubated at 37°C for 24 h to allow newly synthesized, non-
photoactivated PAGFP-SKL molecules to accumulate. The cell 
was then fi  xed to prevent peroxisomes from moving, and  another 
image was collected (post-1st PA t = 24 h). Immediately there-
after, the cell was photoactivated a second time (re-PA) to high-
light all newly synthesized (previously “invisible”) PAGFP-SKL 
molecules, and a fi  nal image was collected (post-2nd PA). The 
image acquired after the second PA (post-2nd PA) was com-
pared with the previous image (i.e., post-1st PA t = 24 h) to 
  determine whether the PAGFP-SKL molecules that were syn-
thesized during the 24 h were only localized to previously 
 fl uorescent peroxisomes or if they were localized to both 
 previously  fl  uorescent peroxisomes and nonfl  uorescent nascent 
peroxisomes within in the cell.
Before photoactivation, no fl   uorescence attributable to 
PAGFP-SKL was observed in a cell coexpressing PAGFP-SKL 
and PEX16-Cerulean (Fig. 7 B, pre-PA; and not depicted). 
However, upon photoactivation, punctate peroxisomes contain-
ing PAGFP-SKL became brightly fl  uorescent (Fig. 7 B, post-1st 
PA t = 0 h). Imaging of the same cell 24 h later revealed a mini-
mal loss of fl  uorescent signal in the cell (Fig. 7 B, post-1st PA 
t = 24 h). Indeed, quantifi  cation of the PAGFP-SKL fl  uores-
cence in different cells throughout the 24-h period revealed that 
the level of fl  uorescence remained virtually constant (Fig. 7 E). 
This suggested that PAGFP-SKL proteins were long-lived and 
that repeated low-light imaging did not lead to their fl  uores-
cence being photobleached. The number of fl  uorescent peroxi-
somes measured at the start and end of this imaging period only 
slightly increased ( 8%), presumably because of peroxisomes 
undergoing fi  ssion (Fig. 7 F, fi  ssion).
After the second photoactivation, the fl  uorescence asso-
ciated with already fl  uorescent peroxisomes increased signifi  -
cantly (Fig. 7 B, compare post-1st PA t = 24 h and post-2nd PA). 
Once formed, therefore, peroxisomes continue to import newly 
synthesized PAGFP-SKL. Notably, fl  uorescence also   appeared 
Figure 7. Peroxisome biogenesis assay. 
(A) Schematic representation of the   peroxisome 
photo-chase biogenesis assay. (B) Images of 
PAGFP-SKL at different time points during the 
assay. (C) Enlargement of the areas outlined 
by the stippled boxes in post-1st PA t = 24 h 
and post-2nd PA in B. Arrows indicate new 
peroxisomes that were observed only after the 
second photoactivation event. (D) Distribution 
of PAGFP-SKL and PEX16-Cerulean after the 
second photoactivation shows that all of the 
photoactivated PAGFP-SKL structures contain 
PEX16-Cerulean. (E) The mean of the total 
  ﬂ   uorescence intensity (n = 3) attributable to 
PAGFP-SKL in the PAGFP-SKL/PEX16-  Cerulean–
expressing NRK cells excited with 488 nm 
plotted over a 24-h period. Images were 
  collected with a fully open pinhole. The total 
ﬂ  uorescence in the cells was calculated by mul-
tiplying the mean pixel value of the whole cell 
with the total number of pixels in the image of 
the cell. Error bars indicates the standard 
  deviation. n = 3. (F) The mean number of per-
oxisomes formed by ﬁ   ssion versus de novo 
pathways. The number of new peroxisomes 
formed by ﬁ  ssion was determined by measur-
ing the difference in the number of peroxi-
somes in the post-1st PA t = 24 h and post-1st 
PA t = 0 images. The number of peroxisomes 
formed de novo was determined by measuring 
the difference between the post-2nd PA and 
post-1st PA t = 24 h images (see Materials and 
methods for additional details). The mean num-
ber of peroxisomes formed by ﬁ   ssion in the 
24-h period was calculated as 11 ± 5 (n = 8), 
whereas a mean of 30 ± 10 (n = 8) new per-
oxisomes were calculated to be formed de 
novo. The difference between these two condi-
tions was determined to be statistically signiﬁ  -
cant (P < 0.05; paired t test). Bars, 10 μm.DE NOVO BIOGENESIS OF PEROXISOMES FROM THE ER • KIM ET AL. 529
in peroxisomes that were not previously fl  uorescent (i.e., per-
oxisomes that did not contain any PAGFP-SKL molecules 
  highlighted during the fi   rst photoactivation step; Fig. 7 B 
[post-2nd PA] and C [higher magnifi  cation, arrows]). These 
“new” peroxisomes were not the result of preexisting peroxi-
somes that had lost their fl  uorescent signal by either degrada-
tion or photobleaching after the initial photoactivation, as the 
total fl  uorescent signal from photoactivated PAGFP-SKL did 
not diminish over the 24-h chase period (Fig. 7 E). Rather, they 
appeared to represent peroxisomes formed de novo during the 
24-h chase period.
Quantifi  cation of the number of newly appearing peroxi-
somes after the second photoactivation event was determined 
by calculating the difference in the number of peroxisomes be-
fore and after the second photoactivation. A mean of 30 ± 10 
new peroxisomes per cell was found based on results from eight 
independent experiments (Fig. 7 F). This represented an  20% 
increase in the total number of peroxisomes in the cell over the 
24-h period and was much greater than the slight increase in 
peroxisomes observed after the fi  rst photoactivation based on 
a t test (t = 2.42; P < 0.05). Therefore, a de novo pathway ap-
peared to play a signifi  cant role in the formation of peroxisomes 
in these cells.
Discussion
In this study, we provide evidence based on live cell imaging 
approaches that peroxisomes in mammalian cells can arise 
de novo from the ER. Using PAGFP and in cellula pulse-chase 
analysis of PAGFP-labeled PEX16 (an early event peroxin), 
we demonstrate that PEX16 traffi  cs normally from the ER to 
peroxisomes and that peroxisomes arise from the ER in wild-
type cells and not only in mutant cells lacking peroxisomes. 
We further show that PEX16 is incorporated into ER-derived 
microsomes cotranslationally and that PEX16 is capable of 
  recruiting other PMPs to membranes. Finally, by visualizing 
the production of peroxisomes within a cell over time using 
PAGFP, we show that most new peroxisomes are derived 
de novo, with possibly only a minor fraction arising from 
fi  ssion of preexisting organelles.
Our fi  ndings complement the growing body of evidence 
from yeast cells, including S. cerevisiae and Y. lipolytica, and 
plant cells indicating that peroxisomes originate from the ER 
and are not semiautonomous organelles like mitochondria or 
chloroplasts (Titorenko and Rachubinski, 1998; Mullen et al., 
1999; Hoepfner et al., 2005; Karnik and Trelease, 2005; Kragt 
et al., 2005; Tam et al., 2005). In addition to solidifying this new 
concept, our results help clarify the role of PEX16 in promoting 
peroxisome outgrowth from the ER and introduce a new pulse-
chase assay using PAGFP in living cells for examining peroxi-
some biogenesis under various physiological conditions.
ER-dependent peroxisome biogenesis
Several lines of evidence for a role of the ER in peroxisome 
biogenesis are presented in this study. First, PEX16-GFP in 
wild-type cells was localized solely in peroxisome and ER 
membranes with no cytosolic pool and was found only in the 
ER in peroxisome-less, PEX19 mutant cells (Fig. 1). Second, 
PEX16 was shown to cotranslationally insert into isolated ER 
microsomes (Fig. 5), and when it was forced to cotranslation-
ally insert into the ER of live cells through the attachment of 
a signal sequence, acquired a topological orientation (Fig. S3; 
Nout-Cout) similar to that reported for PEX16 in peroxisomal 
membranes (Honsho et al., 2002). Third, PEX16 could transit 
from the ER to peroxisomes, indicating that the cotranslational 
targeting of PEX16 into ER was not the fi  nal destination of the 
protein. This latter conclusion was clearly demonstrated using 
a variant of PEX16 tagged with PAGFP. When the ER pool of 
PEX16-PAGFP was photoactivated and followed over time, the 
photoactivated molecules redistributed to peroxisomes (Fig. 2 B). 
Delivery of PEX16 to peroxisomes from the ER was also 
shown to be specifi  c, as photoactivated PEX16 molecules lack-
ing the NH2-terminal membrane peroxisomal targeting se-
quence (delPEX16-PAGFP) were not targeted to peroxisomes 
but instead remained exclusively in the ER (Fig. 2 C). Finally, 
expression of either PEX16- or saPEX16-GFP (PEX16 contain-
ing a signal anchor sequence to ensure its initial membrane 
  integration into the ER) complemented PEX16 function in 
GM06231 cells (which normally lack peroxisomes) and gave 
rise to new peroxisomes (Fig. 4).
Peroxisome maturation from the ER 
in mammalian cells
After its cotranslational targeting to the ER, we envision that 
PEX16 recruits to ER membranes other peroxisomal compo-
nents that are essential for peroxisome biogenesis, including 
PEX3 and other peroxins. These events would then lead to the 
import of additional peroxisomal proteins and result in the 
  differentiation of a “peroxisome-like” domain in the ER that 
eventually would detach from the ER and transform, presum-
ably through some type of maturation process, into a nascent 
mature peroxisome.
Much of our data and those from other studies are consis-
tent with this view. The idea that PEX16 serves as a receptor to 
recruit peroxisome proteins to membranes (Honsho et al., 2002; 
Fang et al., 2004) was supported by our fi  nding that expression 
of PEX16-GFP is suffi  cient to retarget overexpressed PEX3 and 
PMP34 to ER from mitochondria and cytosol, respectively 
(Fig. 6). The differentiation of a peroxisome-like domain in 
the ER has been suggested by EM fi  ndings in mouse dendritic 
cells in which novel lamellae structures containing peroxisomal 
membrane components are observed connected to specialized 
subdomains of the ER (Geuze et al., 2003). Moreover, in 
 peroxisome-defi  cient S. cerevisiae cells lacking the Pex3 gene, 
peroxisomes emerge from specialized areas of the ER upon 
complementation with Pex3-GFP (Hoepfner et al., 2005; Kragt 
et al., 2005; Tam et al., 2005). Finally, new peroxisomes were 
reported to form by a process that was independent of coated 
vesicles (i.e., COPI and -II; South et al., 2000). In line with this, 
we found that photoactivated PEX16-PAGFP in the ER could 
redistribute to peroxisomes when COPI-coated vesicle forma-
tion was blocked with brefeldin A (unpublished data).
Additional work now needs to be done to clarify how such 
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actually occurs. It is possible, for example, that because the 
  dynamin-like protein DLP-1 has been reported to be required 
for peroxisome fi  ssion (Koch et al., 2004), it is likewise involved 
in the budding of nascent peroxisomes from the ER. The differ-
ences in peroxisome import machinery among evolutionarily 
diverse organisms must also be explained. For instance, whereas 
Pex3p in yeast cells readily targets to the ER (Hoepfner et al., 
2005; Kragt et al., 2005; Tam et al., 2005), PEX3 in mammalian 
cells and Pex3p in plant cells appear to be incapable of indepen-
dently targeting to the ER (South et al., 2000; Hunt and  Trelease, 
2004; Jones et al., 2004). Indeed, PEX3 only targets to the 
ER in mammalian cells when it is coexpressed with PEX16 
(Fig. 6 D), which is absent in S. cerevisiae cells (Honsho et al., 
2002). Therefore, one possibility is that the cotranslational in-
sertion of PEX16 into mammalian ER provides the initial “seed” 
or “scaffold” for recruiting other components (e.g., PEX3) that 
are required for peroxisome biogenesis from the ER. How such 
a process would occur in S. cerevisiae cells needs to be further 
addressed, as PEX16 is absent in these cells. Y. lipolytica is the 
only known yeast that expresses a protein, YlPex16p, contain-
ing PEX16 homology. Although YlPex16p shares 24% identity 
to the human PEX16 (Eitzen et al., 1997; South and Gould, 
1999), it is unlikely to function like PEX16 as a PMP receptor. 
This is because YlPex16p is a luminal membrane protein lo-
cated inside of the organelle, whereas PEX16 is a multispan-
ning membrane protein (Eitzen et al., 1997; Titorenko and 
Rachubinski, 1998; Honsho et al., 2002). Instead, YlPex16p 
may serve as a negative regulator of peroxisome division 
(Guo et al., 2003).
Contribution of de novo biogenesis versus 
ﬁ  ssion in the formation of new peroxisomes 
in growing mammalian cells
A critical question for an ER-dependent mode of protein deliv-
ery to peroxisomes is what role this pathway plays in manufac-
turing new peroxisomes in normal, constitutively dividing cells 
in which fi  ssion (division) of preexisting peroxisomes is possi-
ble. To address this question, we devised a novel photo-  labeling, 
pulse-chase strategy for distinguishing newly synthesized from 
previously synthesized peroxisomal protein components and 
for visualizing both “old” and “new” peroxisomes (Fig. 7). 
We found that old peroxisomes contained both newly synthe-
sized and previously synthesized protein components, whereas 
new peroxisomes contained only newly synthesized peroxi-
somal protein components. These fi  ndings argued against fi  s-
sion   being the sole mechanism for mammalian peroxisome 
synthesis and indicated that some other mechanism was respon-
sible for the production of new peroxisomes. One possibility is 
that the new peroxisomes arise from the budding of very small 
structures out from preexisting peroxisomes, as proposed for 
Hansenula polymorpha yeast peroxisomes (Veenhuis et al., 
2000). However, we think this is unlikely because numerous 
EM studies have failed to observe peroxisome budding from 
preexisting peroxisomes in mammalian cells (Novikoff and 
Holtzman 1976; Geuze et al., 2003), and a key peroxisomal 
membrane import component (PEX16) targets indirectly to per-
oxisomes via the ER (Fig. 2). Instead, the simplest interpreta-
tion of our data is that the newly synthesized peroxisomes arise 
by a de novo pathway from the ER, with only a minor fraction 
being formed by fi  ssion of preexisting organelles. Our fi  ndings 
thus help solidify the view that peroxisomes are derived from 
the ER and provide a useful framework for future work aimed 
at understanding how peroxisome proliferation is regulated in 
response to drugs or other physiological conditions.
Materials and methods
Cell lines and reagents
COS-7 and NRK cells were obtained from the American Type Culture 
  Collection. The immortalized PEX19-deﬁ   cient human skin ﬁ  broblast  cell 
line PBD399-T1 and the PEX16-deﬁ   cient human skin ﬁ   broblast cell line 
GM06231 were gifts from S.J. Gould (John Hopkins University School of 
Medicine, Baltimore, MD) and P.A. Walton (University of Western Ontario, 
London, Canada), respectively. All cells were cultured in DME (Biosource 
International) supplemented with 10% heat-inactivated fetal bovine serum 
(Biosource International) and 2 mM glutamine (Invitrogen) at 37°C in 
a humidiﬁ  ed atmosphere containing 5% CO2.
Rabbit anti–mouse HRP antibodies (Sigma-Aldrich), mouse anti-
GFP IgGs (CLONTECH Laboratories, Inc.), Alexa Fluor 546 goat anti–
mouse IgGs, and MitoTracker (Invitrogen) were used according to 
manufacturers’ instructions. Canine pancreatic ER microsomes and rabbit 
reticulocyte lysate were gifts from R.S. Hegde (National Institutes of 
Health, Bethesda, MD). All restriction enzymes were purchased from 
New England Biolabs, Inc.
Plasmids
The construction of pPEX16-GFP was described previously (Brocard 
et al., 2005). pPEX16-PAGFP and -Venus were generated by excising the 
PEX16 ORF from pPEX16-GFP with BglII and SalI and ligating the result-
ing fragment into the same sites in either pmPAGFP-N1 (Patterson and 
  Lippincott-Schwartz, 2002) or pVenus-N1 (Nagai et al., 2002). pdelPEX16-
GFP encoding the PEX16 ORF lacking its mPTS (residues 66–81; -R  K  E  L  R  K  K  L-
P  V  S  L  S  Q  Q  K  -; Honsho et al., 2002) was generated using QuikChange PCR 
site-directed mutagenesis (Stratagene) with pPEX16-GFP as template DNA 
and the complementary synthetic oligonucleotides Fp 5′-G  C  C  G  C  T  C  A  A  T  G-
A  C  G  G  G  A  T  C  C  T  A  A  A  G  C  T  G  C  T  G  A  C  A  T  G  G  C  T  G  A  G  C  G  -3′ and Rp 5′-C  G  C  T-
C  A  G  C  C  A  T  G  T  C  A  G  C  A  G  C  T  T  T  A  G  G  A  T  C  C  C  G  T  C  A  T  T  G  A  G  C  G  G  C  -3′.
The primers Fp 5′-G  T  G  G  T  A  C  C  A  T  G  G  A  G  A  A  G  C  T  G  C  G  G  -3′ and 
Rp 5′-G  T  C  G  A  C  T  C  A  G  C  C  C  C  A  A  C  T  G  T  A  G  -3′ were used to amplify the 
PEX16 ORF, which was then ligated into NcoI–SalI–digested pSPUTK (Kim 
et al., 1997) to yield psUTK-PEX16. psUTK-PEX16-glyc was constructed 
by site-directed mutagenesis of two sites in the PEX16 ORF using the prim-
ers Fp 5′-C  A  C  A  G  C  C  C  T  G  G  C  A  A  C  C  G  A  T  C  G  C  A  G  T  C  C  T  A  C  G  T  G  G  G  G  -3′ 
and Rp 5′-C  C  C  C  A  C  G  T  A  G  G  A  C  T  G  C  G  A  T  C  G  G  T  T  G  C  C  A  G  G  G  C  T  G  T  G  -3′. 
The bolded nucleotides represent mutations that resulted in two amino 
acid substitutions, H162R and E163S, as well as the introduction of an 
N-linked glycosylation consensus site (-N-X-S-) at residues 161–163, along 
with a novel PvuI restriction site for the convenient assessment of mutant 
clones. pSA1 was a gift from R.S Hedge. psaPEX16-GFP was constructed 
by amplifying the sequence encoding amino acid residues 14–90 in SA1 
from pSA1 with the primers Fp 5′-G  A  T  G  C  T  A  G  C  G  A  T  G  G  C  A  A  T  A  T  G  T  T  T  G  C-
C  C  T  G  -3′ and Rp 5′-G  T  C  A  G  C  T  C  T  C  T  G  G  T  A  G  A  T  A  G  G  A  T  C  -3′. The resulting 
PCR products were then digested with NheI and BglII and ligated into 
NheI–BglII–digested pPEX16-GFP.
pPMP34 was a gift from R.J.A. Wanders (University of Amsterdam, 
Amsterdam, Netherlands; Visser et al., 2002). The PMP34 ORF was ampliﬁ  ed 
from pPMP34 with the primers Fp 5′-G  C  T  G  A  A  T  T  C  C  A  C  C  A  T  G  G  C  T  T  C  C  G  T  G  C  T-
G  T  C  C  T  -3′ and Rp 5′-T  T  C  G  G  A  T  C  C  C  G  G  T  G  T  T  G  G  T  G  T  G  C  A  C  G  C  T  T  C  A  G  C  C  -3′, 
PCR products were digested with EcoRI and BamHI and ligated into equivalent 
sites within either pmGFP-N1 or pmCeruleanBlue-N1 to yield pPMP34-GFP 
and -Cerulean, respectively. The pPEX3-GFP and -Cerulean were generated 
by amplifying the PEX3 ORF in pCMV-SPORT-PEX3 (MGC-9125; American 
Type Culture Collection) using the PCR and oligonucleotides Fp 5′-G  A  A  G  A-
T  C  T  G  C  C  A  C  C  A  T  G  C  T  G  A  G  G  T  C  T  G  T  A  T  G  G  A  A  T  T  -3′ and Rp 5′-A  A  A  A  G  T  C  G  A-
C  T  T  C  T  C  C  A  G  T  T  G  C  T  G  A  G  G  G  G  T  A  C  -3′. The resulting products were digested 
with BglII and SalI and then ligated into equivalent sites in either pmGFP-N1 
and pCeruleanBlue-N1. pmRFP- and pPAGFP-SKL were generated using the 
oligonucleotides Fp 5′-C  G  G  G  A  T  C  C  A  C  C  G  G  T  C  G  C  C  A  C  C  A  T  G  -3′ and Rp 
5′-C  A  G  C  G  G  C  C  G  C  T  T  A  A  A  G  C  T  T  G  G  A  G  G  C  G  C  C  G  G  T  G  G  A  G  T  G  G  C  G  -3′ DE NOVO BIOGENESIS OF PEROXISOMES FROM THE ER • KIM ET AL. 531
and either pmRFP-N1 or pmPAGFP-N1 as template DNA. The result-
ing products were digested with BamHI and NotI and then ligated into 
  pmRFP-N1. All plasmids were conﬁ   rmed by automated sequencing. 
The plasmid pssRFP-KDEL (encoding for an RFP molecule containing a 
signal sequence of PPL to target it to the ER lumen and a KDEL sequence 
to retain it there) was a gift from E.L. Snapp (Albert Einstein College of 
Medicine, Bronx, NY).
Cell culturing and sample preparation for microscopy
In preparation for transient transfections, cells were grown in four-well, 
Lab-Tek chambered coverglasses to 70–80% conﬂ  uency. Transient transfec-
tions of COS-7 and NRK cells were performed using FuGENE 6 according 
to the manufacturer’s instructions (Roche Molecular Biochemicals). The 
Lipofectamine 2000 transfection reagent (Invitrogen) was used for PBD399-T1 
and G062351 cells as described by the manufacturer. All transfected 
cells were incubated at 37°C in 5% CO2 for 8–24 h before microscopic 
imaging, unless otherwise noted.
Microscopy and image analysis
All ﬂ  uorescence images were acquired with a laser-scanning confocal mi-
croscope (LSM-510; Carl Zeiss MicroImaging, Inc.) using either a 63× 1.4 
NA Plan-Neoﬂ  uar oil objective (Carl Zeiss MicroImaging, Inc.) or, for photo-
activation and imaging of PEX16-PAGFP, a 40× 1.3 NA Plan-Neoﬂ  uar oil 
objective (Carl Zeiss MicroImaging, Inc.). The imaging of GFP, PAGFP, 
Venus, and Cerulean was performed using 458-, 488-, and 514-nm lines 
of an argon ion laser (Lasos), and the imaging of RFP and Alexa Fluor 543 
was performed using a 543 helium neon laser (Lasos). The dichroic mirrors 
used were 413/488, 458/514, and 488/543, with the appropriate ﬁ  l-
ters supplied by the manufacturer (Carl Zeiss MicroImaging, Inc.) depend-
ing on the ﬂ  uorophore and laser line. All cells were maintained at 37°C 
using an air blower.
For photo/pulse-chase experiments (Fig. 2) photoactivations of 
PAGFP were performed using a 413-nm laser (Coherent Enterprise II) at full 
power in a rectangular ROI. The ROI was selected in an area of the trans-
formed cell that was free of peroxisomes as indicated by RFP-SKL. Photoac-
tivations were repeated once every minute for a period of 30 min.
The de novo peroxiosme biogenesis assay (Fig. 7) was performed 
on NRK cells transfected with pPAGFP-SKL and pPEX16-Cerulean 12–15 h 
before photoactivation. The entire cell expressing PEX16-Cerulean was 
photoactivated using two iterations of a 413-nm laser line at full power in 
a rectangular ROI. Three z section images of 1 μm thickness were col-
lected immediately before and after the photoactivation. 24 h after photo-
activation, cells were ﬁ  xed with 3.7% formaldehyde in phosphate-buffered 
saline for 15 min at room temperature before another round of photo-
activation. Again, three z section images of the cell were collected imme-
diately before and after the second photoactivation. Z sections were 
complied into one projection using the computer software Lview (Carl 
Zeiss MicroImaging, Inc.). ImageJ software (NIH) was used to calculate 
the number of peroxisomes in each cell. In brief, images were converted 
into threshold images that were then analyzed with the ImageJ “analyze 
particle” macro.
FLIP was performed using 25 iterations of a 488-nm laser at full 
strength in a rectangular ROI repeated every 90 s. An image was collected 
immediately before and after each photobleaching session. All images 
were adjusted for brightness and contrast using Photoshop CS (Adobe).
In vitro binding assay
In vitro transcription and translation reactions and the membrane binding 
assay were performed as described previously (Kim et al., 1997). Cotrans-
lational targeting reactions were performed in the presence of 1 equiva-
lence of ER microsomes (1 equivalence = 1 fmol of signal recognition 
particle receptor α-subunit (Walter and Blobel, 1983). Posttranslational 
  reactions were stopped by adding cycloheximide to a ﬁ  nal concentration of
20 μg/ml before adding 1 equivalence of ER microsomes. 1 h after incu-
bation at 24°C, ER microsomes were separated from both cotranslational 
and posttranslational reactions by subjecting each reaction to centrifuga-
tion over a 0.5-M sucrose cushion. Equal amounts of each fraction were 
analyzed by SDS-PAGE using a Tris-Tricine buffer system (Schagger and 
von Jagow, 1987), and radioactive proteins were visualized and quanti-
ﬁ  ed using a phosphorimager (Typhoon; GE Healthcare).
Online supplemental material
Fig. S1 shows the relative expression of GFP-SKL, PEX16-GFP, and 
  saPEX16-GFP over time. Fig. S2 shows the cellular localization of delPEX16-
GFP before and after FLIP. Fig. S3 the differential cell permeabilization
assay of cells expressing ssGFP-KDEL, PEX16-GFP, and saPEX16-GFP. 
Fig. S4 shows cellular localization of PEX3- and PMP34-GFP and the 
colocalization of PEX3-Cerulean with PEX16-Venus in PBD399-T1 cells. 
Online supplemental material is available at http://www.jcb.org/cgi/
content/full/jcb.200601036/DC1.
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